動物用腸内環境の市場:添加物(プロバイオティクス、プレバイオティクス、フィトジェニック、免疫賦活剤)、家畜(家禽、豚、反芻動物、養殖)、形態(乾燥、液体)、供給元、地域別 - 2027年までの世界予測Animal Intestinal Health Market by Additive (Probiotics, Prebiotics, Phytogenics, Immunostimulants), Livestock (Poultry, Swine, Ruminant, Aquaculture), Form (Dry, Liquid), Source, Region - Global Forecast to 2027 2022年に37億米ドルと推定される動物腸管衛生市場は、2022年から2027年にかけて年平均成長率8.2%で54億米ドルに成長すると予測されています。飼料添加物は、動物が摂取する通常の食事に栄養価を与えるものです。... もっと見る
日本語のページは自動翻訳を利用し作成しています。
サマリー2022年に37億米ドルと推定される動物腸管衛生市場は、2022年から2027年にかけて年平均成長率8.2%で54億米ドルに成長すると予測されています。飼料添加物は、動物が摂取する通常の食事に栄養価を与えるものです。人口の増加に伴い、動物の腸内飼料製品も需要の急増を目の当たりにしています。飼料製品の需要増に対応するため、メーカーはプロバイオティクス、プレバイオティクス、フィトジェニック飼料添加物、その他の飼料添加物を活用して、家畜の腸内環境と生産性を高めることに注力しています。肉や乳製品に対する意識の高まり、家畜に関連する健康への懸念、動物加工製品の工業化の進展などが、動物腸管健康市場の世界的な成長を促す主な要因となっています。政府機関による抗生物質の使用に関する規制の実施に伴い、腸内健康を改善するための天然飼料添加物の需要は今後も高く維持されると予想されます。"欧州は2番目に成長の早い地域で、予測期間中に数量ベースで7.62%の成長を目撃すると予測されています。" ヨーロッパの飼料産業は、世界レベルで見ても最大の飼料生産市場の一つです。ヨーロッパの飼料生産者は、家畜のパフォーマンスを向上させるための高品質な飼料製品の需要増加に対応するため、プロバイオティクス、プレバイオティクス、フィトジェニック、免疫賦活剤に基づく様々な飼料添加物を使用しています。この地域のさまざまな飼料メーカーは、家畜のパフォーマンスを向上させるマンナンオリゴ糖やフラクトオリゴ糖などのプレバイオティクスを含めることに重点を置くようになりました。ヨーロッパの飼料生産者は、豚の飼料生産に使用される飼料用抗生物質の代替品として、エッセンシャルオイルなどのフィトジェニックの使用を好んでいます。これらのフィトジェニックは主要な飼料添加物として機能し、飼料摂取量の増加や家畜の腸内機能の改善に役立ちます。 "予測期間中、微生物セグメントがより大きな市場シェアを占めた" 微生物を利用して製造された飼料添加物の増加により、予測期間中、微生物セグメントがより大きな市場シェアを占めました。プロバイオティクスは、豚、反芻動物、家禽などの家畜種において、体重増加、飼料製品の消化率向上、腸内細菌叢全体の強化に役立つとされています。しかし、微生物由来の代替品に関するさまざまな認識が広まるにつれ、フィトジェニックや特定のプレバイオティクスなど、植物由来の腸内健康素材が人気を博しています。 "乾燥形態セグメントが2022年の金額ベースで市場全体の73.64%のシェアを占め、市場を支配しています。" 乾燥した動物用腸内環境改善製品は、液体のものよりも比較的安価であるため、飼料メーカーに好まれています。また、異なる添加物を粉末状にすることで混合が容易になります。乾燥形態は保存期間が長く、輸送も簡単です。これらのことから、飼料メーカーや給餌業者の間で好まれています。 プライマリーの内訳 企業タイプ別Tier1:60.0%、Tier2:25.0%、Tier3:15.0%。 役職別役職別:マネージャー 45.0%、CXO 35.0%、エグゼクティブ 20.0 地域別欧州45%、北米10%、アジア太平洋25%、南米5%、アジア太平洋地域15%。 本レポートに掲載されている主要なプレイヤー 1.カーギル社 (米国) 2.Koninklijke DSM N.V.(オランダ) 3.アーチャー・ダニエルズ・ミッドランド社(米国) 4.デュポン株式会社(米国) 5.エボニックインダストリーズ(ドイツ) 6.ノボザイムズ(デンマーク) 7.ニュートレコ(オランダ) 8.Chr.Hansenホールディングス(デンマーク) 9.ブルースター・アディッセオ・ピーブイティーイー・リミテッド(中国)です。 10.オールテック(米国) 11.エボニックインダストリーズ(ドイツ) 12.ラレマンド社(カナダ) 13.ビオリジン(ブラジル) 14.ランドアンドオレイクス社(米国) 15.レザフレ(フランス) 16.カルピス株式会社(日本) 17.ABビスタ(イギリス) 18.ピュアカルチャーズ(アメリカ) 19.Dr. Eckel Animal Nutrition GmbH & Co.KG(ドイツ) 20.ユニークバイオテック社(インド) 調査対象 本レポートでは、動物用腸内環境市場を添加物、機能、供給源、家畜、形態、地域に基づいて分類しています。本レポートでは、洞察の観点から、競争環境、最終用途分析、企業プロファイルといった様々なレベルの分析に焦点を当てており、これらを合わせて、動物性腸疾患市場の新興および高成長セグメント、高成長地域、国、政府の取り組み、推進要因、阻害要因、機会、課題に関する見解を考察しています。 本レポートを購入する理由 - 動物用腸内環境改善市場の包括的な概要を把握するため。 - 業界のトップ企業、その製品ポートフォリオ、採用した主要戦略に関する幅広い情報を得ることができます。 - 動物用消化器官関連市場の主要国/地域に関する考察を得ることができます。 目次1 INTRODUCTION 301.1 OBJECTIVES OF THE STUDY 30 1.2 MARKET DEFINITION 31 1.3 STUDY SCOPE 31 FIGURE 1 MARKET SEGMENTATION 31 1.3.1 REGIONS COVERED 32 1.4 YEARS CONSIDERED 32 1.5 CURRENCY CONSIDERED 33 TABLE 1 USD EXCHANGE RATES CONSIDERED, 2019-2021 33 1.6 UNIT CONSIDERED 33 1.7 STAKEHOLDERS 33 1.8 SUMMARY OF CHANGES 34 2 RESEARCH METHODOLOGY 35 2.1 RESEARCH DATA 35 FIGURE 2 ANIMAL INTESTINAL HEALTH MARKET: RESEARCH DESIGN 35 2.1.1 SECONDARY DATA 36 2.1.1.1 Key data from secondary sources 36 2.1.2 PRIMARY DATA 36 2.1.2.1 Key data from primary sources 37 2.1.2.2 Breakdown of primary interviews 37 FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY VALUE CHAIN, DESIGNATION, AND REGION 37 2.2 MARKET SIZE ESTIMATION 38 FIGURE 4 ANIMAL INTESTINAL HEALTH MARKET SIZE ESTIMATION: SUPPLY SIDE (1/2) 39 FIGURE 5 ANIMAL INTESTINAL HEALTH MARKET SIZE ESTIMATION: SUPPLY SIDE (2/2) 40 FIGURE 6 ANIMAL INTESTINAL HEALTH MARKET SIZE ESTIMATION: DEMAND SIDE 41 2.2.1 BOTTOM-UP APPROACH 42 FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH 42 2.2.2 TOP-DOWN APPROACH 43 FIGURE 8 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 43 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 44 FIGURE 9 DATA TRIANGULATION METHODOLOGY 44 2.4 RESEARCH ASSUMPTIONS AND LIMITATIONS 45 2.4.1 ASSUMPTIONS 45 2.4.2 LIMITATIONS 46 3 EXECUTIVE SUMMARY 47 FIGURE 10 PROBIOTICS SEGMENT EXPECTED TO ACCOUNT FOR LARGEST MARKET SIZE BY 2027 48 FIGURE 11 POULTRY SEGMENT EXPECTED TO ACCOUNT FOR LARGEST MARKET SIZE BY 2027 48 FIGURE 12 DRY FORM SEGMENT EXPECTED TO ACCOUNT FOR LARGER MARKET SHARE BY 2022 49 FIGURE 13 MICROBIAL SEGMENT EXPECTED TO ACCOUNT FOR LARGER MARKET SIZE BY 2027 49 FIGURE 14 ASIA PACIFIC EXPECTED TO ACCOUNT FOR LARGEST MARKET SHARE IN 2022 50 4 PREMIUM INSIGHTS 51 4.1 OPPORTUNITIES IN ANIMAL INTESTINAL HEALTH MARKET 51 FIGURE 15 INCREASE IN DEMAND FOR FEED AND FEED ADDITIVES DRIVING GROWTH OF ANIMAL INTESTINAL HEALTH MARKET 51 4.2 ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE 51 FIGURE 16 PROBIOTICS SEGMENT EXPECTED TO ACCOUNT FOR LARGEST MARKET SHARE IN 2022 51 4.3 ASIA PACIFIC: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK AND KEY COUNTRIES 52 FIGURE 17 CHINA AND POULTRY SEGMENT EXPECTED TO ACCOUNT FOR SIGNIFICANT MARKET SHARE IN ASIA PACIFIC MARKET IN 2022 52 4.4 ANIMAL INTESTINAL HEALTH MARKET, BY FORM AND REGION 53 FIGURE 18 DRY SEGMENT EXPECTED TO ACCOUNT FOR LARGER MARKET SHARE IN 2022 53 4.5 ANIMAL INTESTINAL HEALTH MARKET, BY MAJOR REGIONAL SUBMARKETS 53 FIGURE 19 CHINA EXPECTED TO ACCOUNT FOR LARGEST MARKET SHARE IN 2022 53 5 MARKET OVERVIEW 54 5.1 INTRODUCTION 54 5.2 MARKET DYNAMICS 54 FIGURE 20 ANIMAL INTESTINAL HEALTH MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 55 5.2.1 DRIVERS 55 5.2.1.1 Increased production of compound feed 55 FIGURE 21 GLOBAL COMPOUND FEED PRODUCTION, 2012–2021 (MILLION METRIC TONS) 56 FIGURE 22 COMPOUND FEED PRODUCTION, BY TOP 7 COUNTRIES, 2016–2020 (MILLION METRIC TONS) 56 5.2.1.2 Rising demand for animal protein 57 TABLE 2 PER CAPITA CONSUMPTION OF LIVESTOCK PRODUCTS, BY REGION 57 5.2.1.3 Intestinal disorders among livestock 58 5.2.2 RESTRAINTS 58 5.2.2.1 Stringent regulations for use of feed additives 58 5.2.3 OPPORTUNITIES 59 5.2.3.1 Innovations and technological advancements in feed industry 59 5.2.3.2 Increased awareness about feed and food safety 59 5.2.4 CHALLENGES 60 5.2.4.1 High cost of feed additives 60 5.2.4.1.1 R&D costs associated with development of probiotics 60 5.2.4.1.2 High cost of active ingredients used in development of phytogenic feed additives 60 6 INDUSTRY TRENDS 61 6.1 INTRODUCTION 61 6.2 TRENDS IMPACTING CUSTOMERS’ BUSINESS 62 FIGURE 23 TRENDS IMPACTING ANIMAL INTESTINAL HEALTH MARKET 62 6.3 VALUE CHAIN 62 FIGURE 24 VALUE CHAIN ANALYSIS 63 6.4 TRADE ANALYSIS 64 FIGURE 25 EXPORT OF LIVESTOCK SPECIES, 2016–2021 (USD MILLION) 64 6.5 TECHNOLOGY ANALYSIS 65 6.6 PATENT ANALYSIS 65 TABLE 3 KEY PATENTS PERTAINING TO ANIMAL INTESTINAL HEALTH, 2019–2022 66 6.7 ECOSYSTEM MAP 67 6.7.1 ANIMAL INTESTINAL HEALTH MARKET: ECOSYSTEM MAP 68 FIGURE 26 FEED AND ANIMAL NUTRITION: ECOSYSTEM MAP 68 6.8 PORTER’S FIVE FORCES ANALYSIS 69 TABLE 4 PORTER’S FIVE FORCES ANALYSIS 69 6.8.1 THREAT OF NEW ENTRANTS 69 6.8.2 THREAT OF SUBSTITUTES 70 6.8.3 BARGAINING POWER OF SUPPLIERS 70 6.8.4 BARGAINING POWER OF BUYERS 70 6.8.5 INTENSITY OF COMPETITIVE RIVALRY 71 6.9 CASE STUDIES 71 6.9.1 REGULATIONS ON ANTIBIOTICS LEADING TO A SHIFT TOWARD PROBIOTICS 71 6.10 PRICING ANALYSIS 72 6.10.1 ANIMAL INTESTINAL HEALTH MARKET: AVERAGE SELLING PRICE TREND ANALYSIS 72 TABLE 5 AVERAGE SELLING PRICE, BY ADDITIVE, 2019–2027 (USD/KG) 72 6.11 REGULATORY FRAMEWORK 73 6.11.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 73 6.11.2 CODEX ALIMENTARIUS COMMISSION (CAC) 73 6.11.2.1 North America 73 6.11.2.2 Europe 74 6.11.2.3 Asia Pacific 75 6.12 KEY STAKEHOLDERS AND BUYING CRITERIA 76 6.12.1 KEY STAKEHOLDERS IN BUYING PROCESS 76 FIGURE 27 INFLUENCE OF STAKEHOLDERS ON BUYING ANIMAL INTESTINAL HEALTH PRODUCTS 76 TABLE 6 INFLUENCE OF STAKEHOLDERS ON TOP THREE PRODUCT TYPES 76 6.12.2 BUYING CRITERIA 77 FIGURE 28 KEY BUYING CRITERIA FOR ADDITIVES 77 TABLE 7 KEY BUYING CRITERIA FOR ADDITIVES 77 6.13 KEY CONFERENCES AND EVENTS, 2022–2023 78 TABLE 8 ANIMAL INTESTINAL HEALTH MARKET: DETAILED LIST OF CONFERENCES & EVENTS, BY REGION, 2022–2023 78 7 ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE 79 7.1 INTRODUCTION 80 FIGURE 29 PROBIOTICS SEGMENT EXPECTED TO DOMINATE ANIMAL INTESTINAL HEALTH MARKET BY 2027 80 TABLE 9 ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2019–2027 (USD MILLION) 81 TABLE 10 ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2019–2027 (KT) 81 7.2 PROBIOTICS 81 7.2.1 PROBIOTIC MICROORGANISMS OFFER HEALTH BENEFITS 81 TABLE 11 PROBIOTICS: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION) 82 TABLE 12 PROBIOTICS: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (KT) 83 7.3 PREBIOTICS 83 7.3.1 PREBIOTICS INDUCE GROWTH OF BENEFICIAL GUT BACTERIA 83 7.3.1.1 Oligosaccharides 84 7.3.1.2 Inulin 84 7.3.1.3 Other additives 85 TABLE 13 PREBIOTICS: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION) 85 TABLE 14 PREBIOTICS: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (KT) 85 7.4 PHYTOGENICS 86 7.4.1 PHYTOGENIC FEED ADDITIVES OFFER MORE THAN FLAVORING PROPERTIES 86 7.4.1.1 Essential oils 86 7.4.1.2 Flavonoids 87 7.4.1.3 Saponins 87 7.4.1.4 Oleoresins 87 7.4.1.5 Other additives 87 TABLE 15 PHYTOGENICS: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION) 88 TABLE 16 PHYTOGENICS: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (KT) 88 7.5 IMMUNOSTIMULANTS 88 7.5.1 IMMUNOSTIMULANTS IMPROVE IMMUNITY AND REDUCE STRESS AND DISEASES IN AQUACULTURE 88 TABLE 17 IMMUNOSTIMULANTS: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION) 89 TABLE 18 IMMUNOSTIMULANTS: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (KT) 89 8 ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK 90 8.1 INTRODUCTION 91 FIGURE 30 POULTRY SEGMENT EXPECTED TO DOMINATE ANIMAL INTESTINAL HEALTH MARKET DURING FORECAST PERIOD 91 TABLE 19 ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 92 TABLE 20 ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (KT) 92 8.2 POULTRY 92 8.2.1 FEED ADDITIVES ENHANCE POULTRY PERFORMANCE 92 TABLE 21 POULTRY: ANIMAL INTESTINAL HEALTH MARKET, BY TYPE, 2019–2027 (USD MILLION) 93 TABLE 22 POULTRY: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION) 93 TABLE 23 POULTRY: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (KT) 93 8.2.1.1 Broilers 94 8.2.1.2 Layers 94 8.2.1.3 Turkey 94 8.2.1.4 Other poultry species 94 8.3 SWINE 95 8.3.1 RISE IN PORK TRADE AND CONCERNS OVER MEAT SAFETY 95 TABLE 24 PROBIOTIC MICROORGANISMS USED IN SWINE FEED 96 TABLE 25 SWINE: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION) 96 TABLE 26 SWINE: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (KT) 97 8.4 RUMINANTS 97 8.4.1 FEED ADDITIVES BOOST PRODUCTION EFFICIENCY IN RUMINANTS 97 TABLE 27 RUMINANTS: ANIMAL INTESTINAL HEALTH MARKET, BY TYPE, 2019–2027 (USD MILLION) 98 TABLE 28 RUMINANTS: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION) 98 TABLE 29 RUMINANTS: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (KT) 98 8.4.1.1 Dairy cattle 99 8.4.1.2 Beef cattle 99 8.4.1.3 Calves 99 8.4.1.4 Other ruminant species 99 8.5 AQUACULTURE 100 8.5.1 FEED ADDITIVES IMPROVE FEED QUALITY AND ENHANCE AQUACULTURE PERFORMANCE 100 TABLE 30 AQUACULTURE: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION) 100 TABLE 31 AQUACULTURE: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (KT) 101 8.6 OTHER LIVESTOCK 101 8.6.1 PHYTOGENIC-BASED ANIMAL INTESTINAL PRODUCTS IMPROVE DIGESTIBILITY IN PETS 101 TABLE 32 OTHER LIVESTOCK: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION) 101 TABLE 33 OTHER LIVESTOCK: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (KT) 102 9 ANIMAL INTESTINAL HEALTH MARKET, BY FORM 103 9.1 INTRODUCTION 104 FIGURE 31 DRY SEGMENT EXPECTED TO DOMINATE ANIMAL INTESTINAL HEALTH MARKET DURING FORECAST PERIOD 104 TABLE 34 ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2019–2027 (USD MILLION) 105 TABLE 35 ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2019–2027 (KT) 105 9.2 DRY 105 9.2.1 EASE OF STORAGE AND TRANSPORTATION 105 TABLE 36 DRY FORM: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION) 106 TABLE 37 DRY FORM: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (KT) 106 9.3 LIQUID 107 9.3.1 LIQUID SUPPLEMENTS PROVIDE UNIFORM TEXTURE TO FINAL PRODUCTS 107 TABLE 38 LIQUID FORM: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION) 108 TABLE 39 LIQUID FORM: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (KT) 108 10 ANIMAL INTESTINAL HEALTH MARKET, BY FUNCTION 109 10.1 METABOLISM 109 10.1.1 ADDITIVES IMPROVE SURVIVAL AND IMPLANTATION OF LIVE MICROBIAL DIETARY SUPPLEMENTS IN GI TRACT 109 10.2 WEIGHT GAIN 109 10.2.1 FEED ADDITIVES IMPROVE PRODUCTION AND PERFORMANCE OF RUMINANTS 109 10.3 NUTRIENT DIGESTION 110 10.3.1 FEED ADDITIVES IMPROVE DIGESTIBILITY OF NUTRIENTS 110 10.4 DISEASE PREVENTION 110 10.4.1 USE OF FEED ADDITIVES PREVENTS DISEASES IN ANIMALS AND IMPROVES HEALTH 110 10.5 BONE AND JOINT HEALTH 111 10.5.1 PREBIOTICS BETTER CALCIUM METABOLISM AND BONE HEALTH 111 11 ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE 112 11.1 INTRODUCTION 113 FIGURE 32 MICROBIAL SEGMENT EXPECTED TO DOMINATE ANIMAL INTESTINAL HEALTH MARKET DURING FORECAST PERIOD 113 TABLE 40 ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2019–2027 (USD MILLION) 113 TABLE 41 ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2019–2027 (KT) 114 11.2 MICROBIAL 114 11.2.1 PROBIOTICS PREPARED USING BACILLUS SUBTILIS AND STREPTOCOCCI IMPROVE EFFICIENCY IN POULTRY AND SWINE 114 TABLE 42 MICROBIAL: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION) 115 TABLE 43 MICROBIAL: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (KT) 115 11.3 PLANT-BASED 116 11.3.1 PLANT-BASED SUBSTANCES IMPROVE NUTRIENT DIGESTIBILITY IN ANIMALS 116 TABLE 44 PLANT-BASED: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION) 117 TABLE 45 PLANT-BASED: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (KT) 117 12 ANIMAL INTESTINAL HEALTH MARKET, BY REGION 118 12.1 INTRODUCTION 119 FIGURE 33 INDIA EXPECTED TO WITNESS HIGH GROWTH IN ANIMAL INTESTINAL HEALTH MARKET BETWEEN 2022 AND 2027 120 TABLE 46 ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION) 120 TABLE 47 ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027(KT) 121 12.2 NORTH AMERICA 121 FIGURE 34 NORTH AMERICA: MARKET SNAPSHOT 122 TABLE 48 NORTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY COUNTRY, 2019–2027 (USD MILLION) 122 TABLE 49 NORTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2019–2027 (USD MILLION) 123 TABLE 50 NORTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2019–2027 (KT) 123 TABLE 51 NORTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 123 TABLE 52 NORTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (KT) 124 TABLE 53 NORTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2019–2027 (USD MILLION) 124 TABLE 54 NORTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2019–2027 (KT) 124 TABLE 55 NORTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2019–2027 (USD MILLION) 124 TABLE 56 NORTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2019–2027 (KT) 125 12.2.1 US 125 12.2.1.1 Rise in consumption of poultry products 125 TABLE 57 US: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 126 12.2.2 CANADA 126 12.2.2.1 Food safety concerns and government regulations 126 TABLE 58 CANADA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 127 12.2.3 MEXICO 127 12.2.3.1 Rise in import of high-quality meat products 127 TABLE 59 MEXICO: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 127 12.3 EUROPE 128 TABLE 60 EUROPE: ANIMAL INTESTINAL HEALTH MARKET, BY COUNTRY, 2019–2027 (USD MILLION) 129 TABLE 61 EUROPE: ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2019–2027 (USD MILLION) 129 TABLE 62 EUROPE: ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2019–2027 (KT) 129 TABLE 63 EUROPE: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 130 TABLE 64 EUROPE: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (KT) 130 TABLE 65 EUROPE: ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2019–2027 (USD MILLION) 130 TABLE 66 EUROPE: ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2019–2027 (KT) 131 TABLE 67 EUROPE: ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2019–2027 (USD MILLION) 131 TABLE 68 EUROPE: ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2019–2027 (KT) 131 12.3.1 SPAIN 131 12.3.1.1 Increased demand for meat and dairy products 131 TABLE 69 SPAIN: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 132 12.3.2 GERMANY 132 12.3.2.1 Focus on offering high-quality meat products 132 TABLE 70 GERMANY: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 132 12.3.3 FRANCE 133 12.3.3.1 Rising instances of disease outbreaks 133 TABLE 71 FRANCE: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 133 12.3.4 ITALY 133 12.3.4.1 Need for alternative growth promoters encourage use of probiotics 133 TABLE 72 ITALY: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 134 12.3.5 UK 134 12.3.5.1 Intensive farming results in high use of premium quality nutrients in animal intestinal health products 134 TABLE 73 UK: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 134 12.3.6 REST OF EUROPE 135 12.3.6.1 Need for alternatives to antibiotic growth promoters encourage demand for phytogenics 135 TABLE 74 REST OF EUROPE: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 135 12.4 ASIA PACIFIC 135 FIGURE 35 ASIA PACIFIC: REGIONAL SNAPSHOT 136 TABLE 75 ASIA PACIFIC: ANIMAL INTESTINAL HEALTH MARKET, BY COUNTRY, 2019–2027 (USD MILLION) 137 TABLE 76 ASIA PACIFIC: ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2019–2027 (USD MILLION) 137 TABLE 77 ASIA PACIFIC: ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2019–2027 (KT) 137 TABLE 78 ASIA PACIFIC: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 138 TABLE 79 ASIA PACIFIC: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (KT) 138 TABLE 80 ASIA PACIFIC: ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2019–2027 (USD MILLION) 138 TABLE 81 ASIA PACIFIC: ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2019–2027 (KT) 138 TABLE 82 ASIA PACIFIC: ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2019–2027 (USD MILLION) 139 TABLE 83 ASIA PACIFIC: ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2019–2027 (KT) 139 12.4.1 CHINA 139 12.4.1.1 High consumption of meat 139 TABLE 84 CHINA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 140 12.4.2 JAPAN 140 12.4.2.1 Preference for high-quality feed products 140 TABLE 85 JAPAN: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 140 12.4.3 INDIA 141 12.4.3.1 Growing demand for high-quality poultry products 141 TABLE 86 INDIA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 141 12.4.4 SOUTH KOREA 141 12.4.4.1 Increase in consumption of meat products 141 TABLE 87 SOUTH KOREA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 142 12.4.5 AUSTRALIA & NEW ZEALAND 142 12.4.5.1 High consumption of meat products 142 TABLE 88 AUSTRALIA & NEW ZEALAND: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 142 12.4.6 REST OF ASIA PACIFIC 143 12.4.6.1 Commercialization of livestock products 143 TABLE 89 REST OF ASIA PACIFIC: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 143 12.5 SOUTH AMERICA 143 TABLE 90 SOUTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY COUNTRY, 2019–2027 (USD MILLION) 143 TABLE 91 SOUTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2019–2027 (USD MILLION) 144 TABLE 92 SOUTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2019–2027 (KT) 144 TABLE 93 SOUTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 144 TABLE 94 SOUTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (KT) 145 TABLE 95 SOUTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2019–2027 (USD MILLION) 145 TABLE 96 SOUTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2019–2027 (KT) 145 TABLE 97 SOUTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2019–2027 (USD MILLION) 145 TABLE 98 SOUTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2019–2027 (KT) 146 12.5.1 BRAZIL 146 12.5.1.1 High demand for meat products due to high purchasing power of people 146 TABLE 99 BRAZIL: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 146 12.5.2 ARGENTINA 147 12.5.2.1 Growth in animal husbandry sector 147 TABLE 100 ARGENTINA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 147 12.5.3 REST OF SOUTH AMERICA 147 12.5.3.1 Increased awareness among farmers about importance of feed supplements 147 TABLE 101 REST OF SOUTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 148 12.6 REST OF THE WORLD 148 TABLE 102 REST OF THE WORLD: ANIMAL INTESTINAL HEALTH MARKET, BY COUNTRY, 2019–2027 (USD MILLION) 148 TABLE 103 REST OF THE WORLD: ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2019–2027 (USD MILLION) 149 TABLE 104 REST OF THE WORLD: ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2019–2027 (KT) 149 TABLE 105 REST OF THE WORLD: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 149 TABLE 106 REST OF THE WORLD: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (KT) 150 TABLE 107 REST OF THE WORLD: ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2019–2027 (USD MILLION) 150 TABLE 108 REST OF THE WORLD: ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2019–2027 (KT) 150 TABLE 109 REST OF THE WORLD: ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2019–2027 (USD MILLION) 151 TABLE 110 REST OF THE WORLD: ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2019–2027 (KT) 151 12.6.1 MIDDLE EAST 151 12.6.1.1 High demand for animal-based protein products 151 TABLE 111 MIDDLE EAST: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 151 12.6.2 AFRICA 152 12.6.2.1 Improvement in livestock health 152 TABLE 112 AFRICA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 152 13 COMPETITIVE LANDSCAPE 153 13.1 OVERVIEW 153 13.2 MARKET EVALUATION FRAMEWORK 154 FIGURE 36 MARKET EVALUATION FRAMEWORK, 2019–2022 154 13.3 MARKET SHARE ANALYSIS 154 TABLE 113 ANIMAL INTESTINAL HEALTH MARKET SHARE ANALYSIS, 2021 155 13.4 REVENUE ANALYSIS FOR KEY COMPANIES, 2019-2021 (USD BILLION) 156 FIGURE 37 REVENUE ANALYSIS OF KEY COMPANIES, 2019-2021 (USD BILLION) 156 13.5 COMPANY EVALUATION QUADRANT 157 13.5.1 STARS 157 13.5.2 EMERGING LEADERS 157 13.5.3 PERVASIVE PLAYERS 157 13.5.4 PARTICIPANTS 157 FIGURE 38 ANIMAL INTESTINAL HEALTH MARKET: COMPANY EVALUATION QUADRANT FOR KEY PLAYERS, 2021 158 13.6 STARTUP EVALUATION QUADRANT 159 13.6.1 PROGRESSIVE COMPANIES 159 13.6.2 STARTING BLOCKS 159 13.6.3 RESPONSIVE COMPANIES 159 13.6.4 DYNAMIC COMPANIES 159 FIGURE 39 ANIMAL INTESTINAL HEALTH MARKET: COMPANY EVALUATION QUADRANT FOR SMES/STARTUPS, 2021 160 13.7 PRODUCT FOOTPRINT (KEY PLAYERS) 161 TABLE 114 COMPANY FOOTPRINT, BY LIVESTOCK 161 TABLE 115 COMPANY FOOTPRINT, BY ADDITIVE 161 TABLE 116 COMPANY FOOTPRINT, BY REGION 162 TABLE 117 OVERALL COMPANY FOOTPRINT 163 13.7.1 COMPETITIVE BENCHMARKING OF KEY PLAYERS 163 TABLE 118 ANIMAL INTESTINAL HEALTH MARKET: DETAILED LIST OF KEY PLAYERS 163 13.7.2 COMPETITIVE BENCHMARKING OF SMES/OTHER PLAYERS 164 TABLE 119 ANIMAL INTESTINAL HEALTH MARKET: DETAILED LIST OF SMES/OTHER PLAYERS 164 13.8 PRODUCT LAUNCHES, DEALS, AND OTHER DEVELOPMENTS 165 13.8.1 NEW PRODUCT LAUNCHES 165 TABLE 120 ANIMAL INTESTINAL HEALTH MARKET: NEW PRODUCT LAUNCHES, 2019-2021 165 13.8.2 OTHER DEVELOPMENTS 166 TABLE 121 ANIMAL INTESTINAL HEALTH MARKET: OTHER DEVELOPMENTS, 2019-2020 166 13.8.3 DEALS 167 TABLE 122 ANIMAL INTESTINAL HEALTH MARKET: DEALS, 2020-2021 167 14 COMPANY PROFILES 168 (Business overview, Products offered, Recent Developments, MNM view)* 14.1 KEY PLAYERS 168 14.1.1 ADM 168 TABLE 123 ADM: BUSINESS OVERVIEW 168 FIGURE 40 ADM: COMPANY SNAPSHOT 169 TABLE 124 ADM: PRODUCTS OFFERED 170 TABLE 125 ADM: OTHERS, 2021 170 TABLE 126 ADM: PRODUCT LAUNCHES, 2020 171 14.1.2 KONINKLIJKE DSM N.V. 172 TABLE 127 KONINKLIJKE DSM N.V.: BUSINESS OVERVIEW 172 FIGURE 41 KONINKLIJKE DSM N.V.: COMPANY SNAPSHOT 173 TABLE 128 KONINKLIJKE DSM N.V.: PRODUCTS OFFERED 173 TABLE 129 KONINKLIJKE DSM N.V.: DEALS, 2020 174 14.1.3 DUPONT NUTRITION & BIOSCIENCES (DANISCO ANIMAL NUTRITION) 176 TABLE 130 DUPONT NUTRITION & BIOSCIENCES: BUSINESS OVERVIEW 176 FIGURE 42 DUPONT NUTRITION & BIOSCIENCES: COMPANY SNAPSHOT 177 TABLE 131 DUPONT NUTRITION & BIOSCIENCES: PRODUCTS OFFERED 177 TABLE 132 DUPONT NUTRITION & BIOSCIENCES: DEALS, 2019-2021 178 TABLE 133 DUPONT NUTRITION & BIOSCIENCES: PRODUCT LAUNCHES, 2019 178 TABLE 134 DUPONT NUTRITION & BIOSCIENCES: OTHERS, 2020 179 14.1.4 CARGILL INCORPORATED 180 TABLE 135 CARGILL INCORPORATED: BUSINESS OVERVIEW 180 FIGURE 43 CARGILL INC.: COMPANY SNAPSHOT 180 TABLE 136 CARGILL INCORPORATED: PRODUCTS OFFERED 181 TABLE 137 CARGILL INCORPORATED: DEALS, 2020 181 TABLE 138 CARGILL INCORPORATED: OTHERS, 2022 181 14.1.5 NOVOZYMES 183 TABLE 139 NOVOZYMES: BUSINESS OVERVIEW 183 FIGURE 44 NOVOZYMES: COMPANY SNAPSHOT 184 TABLE 140 NOVOZYMES: PRODUCTS OFFERED 184 TABLE 141 NOVOZYMES: DEALS, 2020 185 14.1.6 KEMIN INDUSTRIES INC. 186 TABLE 142 KEMIN INDUSTRIES INC.: BUSINESS OVERVIEW 186 TABLE 143 KEMIN INDUSTRIES INC.: PRODUCTS OFFERED 187 TABLE 144 KEMIN INDUSTRIES: PRODUCT LAUNCHES, 2020 187 14.1.7 NUTRECO 188 TABLE 145 NUTRECO: BUSINESS OVERVIEW 188 FIGURE 45 NUTRECO: COMPANY SNAPSHOT 188 TABLE 146 NUTRECO: PRODUCTS OFFERED 189 TABLE 147 NUTRECO: DEALS 2019-2020 189 14.1.8 CHR. HANSEN HOLDING A/S 191 TABLE 148 CHR. HANSEN HOLDING A/S: BUSINESS OVERVIEW 191 FIGURE 46 CHR. HANSEN HOLDING A/S: COMPANY SNAPSHOT 192 TABLE 149 CHR. HANSEN HOLDING A/S: PRODUCTS OFFERED 192 TABLE 150 CHR. HANSEN HOLDING A/S: PRODUCT LAUNCHES, 2019-2021 193 TABLE 151 CHR. HANSEN HOLDING A/S: DEALS, 2020 193 14.1.9 BLUESTAR ADISSEO CO. LTD. 195 TABLE 152 BLUESTAR ADISSEO: BUSINESS OVERVIEW 195 FIGURE 47 BLUESTAR ADISSEO CO. LTD.: COMPANY SNAPSHOT 196 TABLE 153 BLUESTAR ADISSEO CO. LTD.: PRODUCTS OFFERED 196 TABLE 154 BLUESTAR ADISSEO CO. LTD.: DEALS, 2020 197 14.1.10 ALLTECH 199 TABLE 155 ALLTECH: BUSINESS OVERVIEW 199 TABLE 156 ALLTECH: PRODUCTS OFFERED 199 14.1.11 EVONIK INDUSTRIES 201 TABLE 157 EVONIK INDUSTRIES: BUSINESS OVERVIEW 201 FIGURE 48 EVONIK INDUSTRIES: COMPANY SNAPSHOT 202 TABLE 158 EVONIK INDUSTRIES: PRODUCTS OFFERED 202 TABLE 159 EVONIK INDUSTRIES: PRODUCT LAUNCHES, 2020 203 14.1.12 LALLEMAND INC. 204 TABLE 160 LALLEMAND INC.: BUSINESS OVERVIEW 204 TABLE 161 LALLEMAND INC.: PRODUCTS OFFERED 204 TABLE 162 LALLEMAND INC.: OTHER DEVELOPMENTS, 2019-2020 205 14.1.13 BIORIGIN 206 TABLE 163 BIORIGIN: BUSINESS OVERVIEW 206 TABLE 164 BIORIGIN: PRODUCTS OFFERED 206 TABLE 165 BIORIGIN: DEALS, 2019 207 14.1.14 LAND O’LAKES 208 TABLE 166 LAND O’LAKES: BUSINESS OVERVIEW 208 FIGURE 49 LAND O’LAKES: COMPANY SNAPSHOT 208 TABLE 167 LAND O’LAKES: PRODUCTS OFFERED 209 TABLE 168 LAND O’LAKES: OTHERS, 2019 209 TABLE 169 LAND O’LAKES: DEALS, 2019 210 14.1.15 LESAFFRE 211 TABLE 170 LESAFFRE: BUSINESS OVERVIEW 211 TABLE 171 LESAFFRE: PRODUCTS OFFERED 211 TABLE 172 LESAFFRE: OTHER DEVELOPMENTS, 2019-2020 212 TABLE 173 LESAFFRE: PRODUCT LAUNCHES, 2019 212 14.1.16 CALPIS CO LTD 214 TABLE 174 CALPIS CO LTD.: BUSINESS OVERVIEW 214 14.1.17 AB VISTA 215 14.1.18 PURE CULTURES 215 14.1.19 DR. ECKEL ANIMAL NUTRITION GMBH & CO. KG 216 14.1.20 UNIQUE BIOTECH 217 *Details on Business overview, Products offered, Recent Developments, MNM view might not be captured in case of unlisted companies. 15 ADJACENT AND RELATED MARKETS 218 15.1 INTRODUCTION 218 TABLE 175 ADJACENT MARKETS TO ANIMAL INTESTINAL HEALTH 218 15.2 LIMITATIONS 218 15.3 PHYTOGENIC FEED ADDITIVES MARKET 219 15.3.1 MARKET DEFINITION 219 15.3.2 MARKET OVERVIEW 219 TABLE 176 PHYTOGENIC FEED ADDITIVES MARKET, BY SOURCE, 2016–2019 (USD MILLION) 219 TABLE 177 PHYTOGENIC FEED ADDITIVES MARKET, BY SOURCE, 2020–2025 (USD MILLION) 220 15.4 PROBIOTICS IN ANIMAL FEED MARKET 220 15.4.1 MARKET DEFINITION 220 TABLE 178 PROBIOTICS IN ANIMAL FEED MARKET, BY LIVESTOCK, 2017–2020 (USD MILLION) 220 TABLE 179 PROBIOTICS IN ANIMAL FEED MARKET, BY LIVESTOCK, 2021–2026 (USD MILLION) 221 16 APPENDIX 222 16.1 DISCUSSION GUIDE 222 16.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 226 16.3 AVAILABLE CUSTOMIZATION 228 16.4 RELATED REPORTS 229 16.5 AUTHOR DETAILS 230
SummaryThe animal intestinal health market, estimated at USD 3.7 billion in 2022 and is projected to grow to USD 5.4 billion in 2027, at a CAGR of 8.2% from 2022 to 2027. Feed additives provide nutritional value to the regular meal consumed by animals. With the increase in population, animal intestinal feed products have also witnessed a surge in demand. To cater to the growing demand for feed products, manufacturers are focusing on utilizing probiotics, prebiotics, phytogenic feed additives, and other feed additives to enhance the gut health and productivity of livestock. The rise in awareness about meat and dairy products, health concerns related to livestock, and the increase in the industrialization of animal-processed products are the major factors driving the growth of the animal intestinal health market globally. With the imposition of regulations by government agencies on the use of antibiotics, the demand for natural feed additives to improve the quality of intestinal health products is expected to remain high. Table of Contents1 INTRODUCTION 301.1 OBJECTIVES OF THE STUDY 30 1.2 MARKET DEFINITION 31 1.3 STUDY SCOPE 31 FIGURE 1 MARKET SEGMENTATION 31 1.3.1 REGIONS COVERED 32 1.4 YEARS CONSIDERED 32 1.5 CURRENCY CONSIDERED 33 TABLE 1 USD EXCHANGE RATES CONSIDERED, 2019-2021 33 1.6 UNIT CONSIDERED 33 1.7 STAKEHOLDERS 33 1.8 SUMMARY OF CHANGES 34 2 RESEARCH METHODOLOGY 35 2.1 RESEARCH DATA 35 FIGURE 2 ANIMAL INTESTINAL HEALTH MARKET: RESEARCH DESIGN 35 2.1.1 SECONDARY DATA 36 2.1.1.1 Key data from secondary sources 36 2.1.2 PRIMARY DATA 36 2.1.2.1 Key data from primary sources 37 2.1.2.2 Breakdown of primary interviews 37 FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY VALUE CHAIN, DESIGNATION, AND REGION 37 2.2 MARKET SIZE ESTIMATION 38 FIGURE 4 ANIMAL INTESTINAL HEALTH MARKET SIZE ESTIMATION: SUPPLY SIDE (1/2) 39 FIGURE 5 ANIMAL INTESTINAL HEALTH MARKET SIZE ESTIMATION: SUPPLY SIDE (2/2) 40 FIGURE 6 ANIMAL INTESTINAL HEALTH MARKET SIZE ESTIMATION: DEMAND SIDE 41 2.2.1 BOTTOM-UP APPROACH 42 FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH 42 2.2.2 TOP-DOWN APPROACH 43 FIGURE 8 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 43 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 44 FIGURE 9 DATA TRIANGULATION METHODOLOGY 44 2.4 RESEARCH ASSUMPTIONS AND LIMITATIONS 45 2.4.1 ASSUMPTIONS 45 2.4.2 LIMITATIONS 46 3 EXECUTIVE SUMMARY 47 FIGURE 10 PROBIOTICS SEGMENT EXPECTED TO ACCOUNT FOR LARGEST MARKET SIZE BY 2027 48 FIGURE 11 POULTRY SEGMENT EXPECTED TO ACCOUNT FOR LARGEST MARKET SIZE BY 2027 48 FIGURE 12 DRY FORM SEGMENT EXPECTED TO ACCOUNT FOR LARGER MARKET SHARE BY 2022 49 FIGURE 13 MICROBIAL SEGMENT EXPECTED TO ACCOUNT FOR LARGER MARKET SIZE BY 2027 49 FIGURE 14 ASIA PACIFIC EXPECTED TO ACCOUNT FOR LARGEST MARKET SHARE IN 2022 50 4 PREMIUM INSIGHTS 51 4.1 OPPORTUNITIES IN ANIMAL INTESTINAL HEALTH MARKET 51 FIGURE 15 INCREASE IN DEMAND FOR FEED AND FEED ADDITIVES DRIVING GROWTH OF ANIMAL INTESTINAL HEALTH MARKET 51 4.2 ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE 51 FIGURE 16 PROBIOTICS SEGMENT EXPECTED TO ACCOUNT FOR LARGEST MARKET SHARE IN 2022 51 4.3 ASIA PACIFIC: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK AND KEY COUNTRIES 52 FIGURE 17 CHINA AND POULTRY SEGMENT EXPECTED TO ACCOUNT FOR SIGNIFICANT MARKET SHARE IN ASIA PACIFIC MARKET IN 2022 52 4.4 ANIMAL INTESTINAL HEALTH MARKET, BY FORM AND REGION 53 FIGURE 18 DRY SEGMENT EXPECTED TO ACCOUNT FOR LARGER MARKET SHARE IN 2022 53 4.5 ANIMAL INTESTINAL HEALTH MARKET, BY MAJOR REGIONAL SUBMARKETS 53 FIGURE 19 CHINA EXPECTED TO ACCOUNT FOR LARGEST MARKET SHARE IN 2022 53 5 MARKET OVERVIEW 54 5.1 INTRODUCTION 54 5.2 MARKET DYNAMICS 54 FIGURE 20 ANIMAL INTESTINAL HEALTH MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 55 5.2.1 DRIVERS 55 5.2.1.1 Increased production of compound feed 55 FIGURE 21 GLOBAL COMPOUND FEED PRODUCTION, 2012–2021 (MILLION METRIC TONS) 56 FIGURE 22 COMPOUND FEED PRODUCTION, BY TOP 7 COUNTRIES, 2016–2020 (MILLION METRIC TONS) 56 5.2.1.2 Rising demand for animal protein 57 TABLE 2 PER CAPITA CONSUMPTION OF LIVESTOCK PRODUCTS, BY REGION 57 5.2.1.3 Intestinal disorders among livestock 58 5.2.2 RESTRAINTS 58 5.2.2.1 Stringent regulations for use of feed additives 58 5.2.3 OPPORTUNITIES 59 5.2.3.1 Innovations and technological advancements in feed industry 59 5.2.3.2 Increased awareness about feed and food safety 59 5.2.4 CHALLENGES 60 5.2.4.1 High cost of feed additives 60 5.2.4.1.1 R&D costs associated with development of probiotics 60 5.2.4.1.2 High cost of active ingredients used in development of phytogenic feed additives 60 6 INDUSTRY TRENDS 61 6.1 INTRODUCTION 61 6.2 TRENDS IMPACTING CUSTOMERS’ BUSINESS 62 FIGURE 23 TRENDS IMPACTING ANIMAL INTESTINAL HEALTH MARKET 62 6.3 VALUE CHAIN 62 FIGURE 24 VALUE CHAIN ANALYSIS 63 6.4 TRADE ANALYSIS 64 FIGURE 25 EXPORT OF LIVESTOCK SPECIES, 2016–2021 (USD MILLION) 64 6.5 TECHNOLOGY ANALYSIS 65 6.6 PATENT ANALYSIS 65 TABLE 3 KEY PATENTS PERTAINING TO ANIMAL INTESTINAL HEALTH, 2019–2022 66 6.7 ECOSYSTEM MAP 67 6.7.1 ANIMAL INTESTINAL HEALTH MARKET: ECOSYSTEM MAP 68 FIGURE 26 FEED AND ANIMAL NUTRITION: ECOSYSTEM MAP 68 6.8 PORTER’S FIVE FORCES ANALYSIS 69 TABLE 4 PORTER’S FIVE FORCES ANALYSIS 69 6.8.1 THREAT OF NEW ENTRANTS 69 6.8.2 THREAT OF SUBSTITUTES 70 6.8.3 BARGAINING POWER OF SUPPLIERS 70 6.8.4 BARGAINING POWER OF BUYERS 70 6.8.5 INTENSITY OF COMPETITIVE RIVALRY 71 6.9 CASE STUDIES 71 6.9.1 REGULATIONS ON ANTIBIOTICS LEADING TO A SHIFT TOWARD PROBIOTICS 71 6.10 PRICING ANALYSIS 72 6.10.1 ANIMAL INTESTINAL HEALTH MARKET: AVERAGE SELLING PRICE TREND ANALYSIS 72 TABLE 5 AVERAGE SELLING PRICE, BY ADDITIVE, 2019–2027 (USD/KG) 72 6.11 REGULATORY FRAMEWORK 73 6.11.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 73 6.11.2 CODEX ALIMENTARIUS COMMISSION (CAC) 73 6.11.2.1 North America 73 6.11.2.2 Europe 74 6.11.2.3 Asia Pacific 75 6.12 KEY STAKEHOLDERS AND BUYING CRITERIA 76 6.12.1 KEY STAKEHOLDERS IN BUYING PROCESS 76 FIGURE 27 INFLUENCE OF STAKEHOLDERS ON BUYING ANIMAL INTESTINAL HEALTH PRODUCTS 76 TABLE 6 INFLUENCE OF STAKEHOLDERS ON TOP THREE PRODUCT TYPES 76 6.12.2 BUYING CRITERIA 77 FIGURE 28 KEY BUYING CRITERIA FOR ADDITIVES 77 TABLE 7 KEY BUYING CRITERIA FOR ADDITIVES 77 6.13 KEY CONFERENCES AND EVENTS, 2022–2023 78 TABLE 8 ANIMAL INTESTINAL HEALTH MARKET: DETAILED LIST OF CONFERENCES & EVENTS, BY REGION, 2022–2023 78 7 ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE 79 7.1 INTRODUCTION 80 FIGURE 29 PROBIOTICS SEGMENT EXPECTED TO DOMINATE ANIMAL INTESTINAL HEALTH MARKET BY 2027 80 TABLE 9 ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2019–2027 (USD MILLION) 81 TABLE 10 ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2019–2027 (KT) 81 7.2 PROBIOTICS 81 7.2.1 PROBIOTIC MICROORGANISMS OFFER HEALTH BENEFITS 81 TABLE 11 PROBIOTICS: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION) 82 TABLE 12 PROBIOTICS: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (KT) 83 7.3 PREBIOTICS 83 7.3.1 PREBIOTICS INDUCE GROWTH OF BENEFICIAL GUT BACTERIA 83 7.3.1.1 Oligosaccharides 84 7.3.1.2 Inulin 84 7.3.1.3 Other additives 85 TABLE 13 PREBIOTICS: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION) 85 TABLE 14 PREBIOTICS: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (KT) 85 7.4 PHYTOGENICS 86 7.4.1 PHYTOGENIC FEED ADDITIVES OFFER MORE THAN FLAVORING PROPERTIES 86 7.4.1.1 Essential oils 86 7.4.1.2 Flavonoids 87 7.4.1.3 Saponins 87 7.4.1.4 Oleoresins 87 7.4.1.5 Other additives 87 TABLE 15 PHYTOGENICS: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION) 88 TABLE 16 PHYTOGENICS: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (KT) 88 7.5 IMMUNOSTIMULANTS 88 7.5.1 IMMUNOSTIMULANTS IMPROVE IMMUNITY AND REDUCE STRESS AND DISEASES IN AQUACULTURE 88 TABLE 17 IMMUNOSTIMULANTS: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION) 89 TABLE 18 IMMUNOSTIMULANTS: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (KT) 89 8 ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK 90 8.1 INTRODUCTION 91 FIGURE 30 POULTRY SEGMENT EXPECTED TO DOMINATE ANIMAL INTESTINAL HEALTH MARKET DURING FORECAST PERIOD 91 TABLE 19 ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 92 TABLE 20 ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (KT) 92 8.2 POULTRY 92 8.2.1 FEED ADDITIVES ENHANCE POULTRY PERFORMANCE 92 TABLE 21 POULTRY: ANIMAL INTESTINAL HEALTH MARKET, BY TYPE, 2019–2027 (USD MILLION) 93 TABLE 22 POULTRY: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION) 93 TABLE 23 POULTRY: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (KT) 93 8.2.1.1 Broilers 94 8.2.1.2 Layers 94 8.2.1.3 Turkey 94 8.2.1.4 Other poultry species 94 8.3 SWINE 95 8.3.1 RISE IN PORK TRADE AND CONCERNS OVER MEAT SAFETY 95 TABLE 24 PROBIOTIC MICROORGANISMS USED IN SWINE FEED 96 TABLE 25 SWINE: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION) 96 TABLE 26 SWINE: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (KT) 97 8.4 RUMINANTS 97 8.4.1 FEED ADDITIVES BOOST PRODUCTION EFFICIENCY IN RUMINANTS 97 TABLE 27 RUMINANTS: ANIMAL INTESTINAL HEALTH MARKET, BY TYPE, 2019–2027 (USD MILLION) 98 TABLE 28 RUMINANTS: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION) 98 TABLE 29 RUMINANTS: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (KT) 98 8.4.1.1 Dairy cattle 99 8.4.1.2 Beef cattle 99 8.4.1.3 Calves 99 8.4.1.4 Other ruminant species 99 8.5 AQUACULTURE 100 8.5.1 FEED ADDITIVES IMPROVE FEED QUALITY AND ENHANCE AQUACULTURE PERFORMANCE 100 TABLE 30 AQUACULTURE: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION) 100 TABLE 31 AQUACULTURE: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (KT) 101 8.6 OTHER LIVESTOCK 101 8.6.1 PHYTOGENIC-BASED ANIMAL INTESTINAL PRODUCTS IMPROVE DIGESTIBILITY IN PETS 101 TABLE 32 OTHER LIVESTOCK: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION) 101 TABLE 33 OTHER LIVESTOCK: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (KT) 102 9 ANIMAL INTESTINAL HEALTH MARKET, BY FORM 103 9.1 INTRODUCTION 104 FIGURE 31 DRY SEGMENT EXPECTED TO DOMINATE ANIMAL INTESTINAL HEALTH MARKET DURING FORECAST PERIOD 104 TABLE 34 ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2019–2027 (USD MILLION) 105 TABLE 35 ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2019–2027 (KT) 105 9.2 DRY 105 9.2.1 EASE OF STORAGE AND TRANSPORTATION 105 TABLE 36 DRY FORM: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION) 106 TABLE 37 DRY FORM: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (KT) 106 9.3 LIQUID 107 9.3.1 LIQUID SUPPLEMENTS PROVIDE UNIFORM TEXTURE TO FINAL PRODUCTS 107 TABLE 38 LIQUID FORM: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION) 108 TABLE 39 LIQUID FORM: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (KT) 108 10 ANIMAL INTESTINAL HEALTH MARKET, BY FUNCTION 109 10.1 METABOLISM 109 10.1.1 ADDITIVES IMPROVE SURVIVAL AND IMPLANTATION OF LIVE MICROBIAL DIETARY SUPPLEMENTS IN GI TRACT 109 10.2 WEIGHT GAIN 109 10.2.1 FEED ADDITIVES IMPROVE PRODUCTION AND PERFORMANCE OF RUMINANTS 109 10.3 NUTRIENT DIGESTION 110 10.3.1 FEED ADDITIVES IMPROVE DIGESTIBILITY OF NUTRIENTS 110 10.4 DISEASE PREVENTION 110 10.4.1 USE OF FEED ADDITIVES PREVENTS DISEASES IN ANIMALS AND IMPROVES HEALTH 110 10.5 BONE AND JOINT HEALTH 111 10.5.1 PREBIOTICS BETTER CALCIUM METABOLISM AND BONE HEALTH 111 11 ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE 112 11.1 INTRODUCTION 113 FIGURE 32 MICROBIAL SEGMENT EXPECTED TO DOMINATE ANIMAL INTESTINAL HEALTH MARKET DURING FORECAST PERIOD 113 TABLE 40 ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2019–2027 (USD MILLION) 113 TABLE 41 ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2019–2027 (KT) 114 11.2 MICROBIAL 114 11.2.1 PROBIOTICS PREPARED USING BACILLUS SUBTILIS AND STREPTOCOCCI IMPROVE EFFICIENCY IN POULTRY AND SWINE 114 TABLE 42 MICROBIAL: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION) 115 TABLE 43 MICROBIAL: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (KT) 115 11.3 PLANT-BASED 116 11.3.1 PLANT-BASED SUBSTANCES IMPROVE NUTRIENT DIGESTIBILITY IN ANIMALS 116 TABLE 44 PLANT-BASED: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION) 117 TABLE 45 PLANT-BASED: ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (KT) 117 12 ANIMAL INTESTINAL HEALTH MARKET, BY REGION 118 12.1 INTRODUCTION 119 FIGURE 33 INDIA EXPECTED TO WITNESS HIGH GROWTH IN ANIMAL INTESTINAL HEALTH MARKET BETWEEN 2022 AND 2027 120 TABLE 46 ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027 (USD MILLION) 120 TABLE 47 ANIMAL INTESTINAL HEALTH MARKET, BY REGION, 2019–2027(KT) 121 12.2 NORTH AMERICA 121 FIGURE 34 NORTH AMERICA: MARKET SNAPSHOT 122 TABLE 48 NORTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY COUNTRY, 2019–2027 (USD MILLION) 122 TABLE 49 NORTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2019–2027 (USD MILLION) 123 TABLE 50 NORTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2019–2027 (KT) 123 TABLE 51 NORTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 123 TABLE 52 NORTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (KT) 124 TABLE 53 NORTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2019–2027 (USD MILLION) 124 TABLE 54 NORTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2019–2027 (KT) 124 TABLE 55 NORTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2019–2027 (USD MILLION) 124 TABLE 56 NORTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2019–2027 (KT) 125 12.2.1 US 125 12.2.1.1 Rise in consumption of poultry products 125 TABLE 57 US: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 126 12.2.2 CANADA 126 12.2.2.1 Food safety concerns and government regulations 126 TABLE 58 CANADA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 127 12.2.3 MEXICO 127 12.2.3.1 Rise in import of high-quality meat products 127 TABLE 59 MEXICO: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 127 12.3 EUROPE 128 TABLE 60 EUROPE: ANIMAL INTESTINAL HEALTH MARKET, BY COUNTRY, 2019–2027 (USD MILLION) 129 TABLE 61 EUROPE: ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2019–2027 (USD MILLION) 129 TABLE 62 EUROPE: ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2019–2027 (KT) 129 TABLE 63 EUROPE: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 130 TABLE 64 EUROPE: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (KT) 130 TABLE 65 EUROPE: ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2019–2027 (USD MILLION) 130 TABLE 66 EUROPE: ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2019–2027 (KT) 131 TABLE 67 EUROPE: ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2019–2027 (USD MILLION) 131 TABLE 68 EUROPE: ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2019–2027 (KT) 131 12.3.1 SPAIN 131 12.3.1.1 Increased demand for meat and dairy products 131 TABLE 69 SPAIN: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 132 12.3.2 GERMANY 132 12.3.2.1 Focus on offering high-quality meat products 132 TABLE 70 GERMANY: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 132 12.3.3 FRANCE 133 12.3.3.1 Rising instances of disease outbreaks 133 TABLE 71 FRANCE: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 133 12.3.4 ITALY 133 12.3.4.1 Need for alternative growth promoters encourage use of probiotics 133 TABLE 72 ITALY: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 134 12.3.5 UK 134 12.3.5.1 Intensive farming results in high use of premium quality nutrients in animal intestinal health products 134 TABLE 73 UK: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 134 12.3.6 REST OF EUROPE 135 12.3.6.1 Need for alternatives to antibiotic growth promoters encourage demand for phytogenics 135 TABLE 74 REST OF EUROPE: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 135 12.4 ASIA PACIFIC 135 FIGURE 35 ASIA PACIFIC: REGIONAL SNAPSHOT 136 TABLE 75 ASIA PACIFIC: ANIMAL INTESTINAL HEALTH MARKET, BY COUNTRY, 2019–2027 (USD MILLION) 137 TABLE 76 ASIA PACIFIC: ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2019–2027 (USD MILLION) 137 TABLE 77 ASIA PACIFIC: ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2019–2027 (KT) 137 TABLE 78 ASIA PACIFIC: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 138 TABLE 79 ASIA PACIFIC: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (KT) 138 TABLE 80 ASIA PACIFIC: ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2019–2027 (USD MILLION) 138 TABLE 81 ASIA PACIFIC: ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2019–2027 (KT) 138 TABLE 82 ASIA PACIFIC: ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2019–2027 (USD MILLION) 139 TABLE 83 ASIA PACIFIC: ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2019–2027 (KT) 139 12.4.1 CHINA 139 12.4.1.1 High consumption of meat 139 TABLE 84 CHINA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 140 12.4.2 JAPAN 140 12.4.2.1 Preference for high-quality feed products 140 TABLE 85 JAPAN: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 140 12.4.3 INDIA 141 12.4.3.1 Growing demand for high-quality poultry products 141 TABLE 86 INDIA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 141 12.4.4 SOUTH KOREA 141 12.4.4.1 Increase in consumption of meat products 141 TABLE 87 SOUTH KOREA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 142 12.4.5 AUSTRALIA & NEW ZEALAND 142 12.4.5.1 High consumption of meat products 142 TABLE 88 AUSTRALIA & NEW ZEALAND: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 142 12.4.6 REST OF ASIA PACIFIC 143 12.4.6.1 Commercialization of livestock products 143 TABLE 89 REST OF ASIA PACIFIC: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 143 12.5 SOUTH AMERICA 143 TABLE 90 SOUTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY COUNTRY, 2019–2027 (USD MILLION) 143 TABLE 91 SOUTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2019–2027 (USD MILLION) 144 TABLE 92 SOUTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2019–2027 (KT) 144 TABLE 93 SOUTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 144 TABLE 94 SOUTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (KT) 145 TABLE 95 SOUTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2019–2027 (USD MILLION) 145 TABLE 96 SOUTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2019–2027 (KT) 145 TABLE 97 SOUTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2019–2027 (USD MILLION) 145 TABLE 98 SOUTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2019–2027 (KT) 146 12.5.1 BRAZIL 146 12.5.1.1 High demand for meat products due to high purchasing power of people 146 TABLE 99 BRAZIL: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 146 12.5.2 ARGENTINA 147 12.5.2.1 Growth in animal husbandry sector 147 TABLE 100 ARGENTINA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 147 12.5.3 REST OF SOUTH AMERICA 147 12.5.3.1 Increased awareness among farmers about importance of feed supplements 147 TABLE 101 REST OF SOUTH AMERICA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 148 12.6 REST OF THE WORLD 148 TABLE 102 REST OF THE WORLD: ANIMAL INTESTINAL HEALTH MARKET, BY COUNTRY, 2019–2027 (USD MILLION) 148 TABLE 103 REST OF THE WORLD: ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2019–2027 (USD MILLION) 149 TABLE 104 REST OF THE WORLD: ANIMAL INTESTINAL HEALTH MARKET, BY ADDITIVE, 2019–2027 (KT) 149 TABLE 105 REST OF THE WORLD: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 149 TABLE 106 REST OF THE WORLD: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (KT) 150 TABLE 107 REST OF THE WORLD: ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2019–2027 (USD MILLION) 150 TABLE 108 REST OF THE WORLD: ANIMAL INTESTINAL HEALTH MARKET, BY SOURCE, 2019–2027 (KT) 150 TABLE 109 REST OF THE WORLD: ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2019–2027 (USD MILLION) 151 TABLE 110 REST OF THE WORLD: ANIMAL INTESTINAL HEALTH MARKET, BY FORM, 2019–2027 (KT) 151 12.6.1 MIDDLE EAST 151 12.6.1.1 High demand for animal-based protein products 151 TABLE 111 MIDDLE EAST: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 151 12.6.2 AFRICA 152 12.6.2.1 Improvement in livestock health 152 TABLE 112 AFRICA: ANIMAL INTESTINAL HEALTH MARKET, BY LIVESTOCK, 2019–2027 (USD MILLION) 152 13 COMPETITIVE LANDSCAPE 153 13.1 OVERVIEW 153 13.2 MARKET EVALUATION FRAMEWORK 154 FIGURE 36 MARKET EVALUATION FRAMEWORK, 2019–2022 154 13.3 MARKET SHARE ANALYSIS 154 TABLE 113 ANIMAL INTESTINAL HEALTH MARKET SHARE ANALYSIS, 2021 155 13.4 REVENUE ANALYSIS FOR KEY COMPANIES, 2019-2021 (USD BILLION) 156 FIGURE 37 REVENUE ANALYSIS OF KEY COMPANIES, 2019-2021 (USD BILLION) 156 13.5 COMPANY EVALUATION QUADRANT 157 13.5.1 STARS 157 13.5.2 EMERGING LEADERS 157 13.5.3 PERVASIVE PLAYERS 157 13.5.4 PARTICIPANTS 157 FIGURE 38 ANIMAL INTESTINAL HEALTH MARKET: COMPANY EVALUATION QUADRANT FOR KEY PLAYERS, 2021 158 13.6 STARTUP EVALUATION QUADRANT 159 13.6.1 PROGRESSIVE COMPANIES 159 13.6.2 STARTING BLOCKS 159 13.6.3 RESPONSIVE COMPANIES 159 13.6.4 DYNAMIC COMPANIES 159 FIGURE 39 ANIMAL INTESTINAL HEALTH MARKET: COMPANY EVALUATION QUADRANT FOR SMES/STARTUPS, 2021 160 13.7 PRODUCT FOOTPRINT (KEY PLAYERS) 161 TABLE 114 COMPANY FOOTPRINT, BY LIVESTOCK 161 TABLE 115 COMPANY FOOTPRINT, BY ADDITIVE 161 TABLE 116 COMPANY FOOTPRINT, BY REGION 162 TABLE 117 OVERALL COMPANY FOOTPRINT 163 13.7.1 COMPETITIVE BENCHMARKING OF KEY PLAYERS 163 TABLE 118 ANIMAL INTESTINAL HEALTH MARKET: DETAILED LIST OF KEY PLAYERS 163 13.7.2 COMPETITIVE BENCHMARKING OF SMES/OTHER PLAYERS 164 TABLE 119 ANIMAL INTESTINAL HEALTH MARKET: DETAILED LIST OF SMES/OTHER PLAYERS 164 13.8 PRODUCT LAUNCHES, DEALS, AND OTHER DEVELOPMENTS 165 13.8.1 NEW PRODUCT LAUNCHES 165 TABLE 120 ANIMAL INTESTINAL HEALTH MARKET: NEW PRODUCT LAUNCHES, 2019-2021 165 13.8.2 OTHER DEVELOPMENTS 166 TABLE 121 ANIMAL INTESTINAL HEALTH MARKET: OTHER DEVELOPMENTS, 2019-2020 166 13.8.3 DEALS 167 TABLE 122 ANIMAL INTESTINAL HEALTH MARKET: DEALS, 2020-2021 167 14 COMPANY PROFILES 168 (Business overview, Products offered, Recent Developments, MNM view)* 14.1 KEY PLAYERS 168 14.1.1 ADM 168 TABLE 123 ADM: BUSINESS OVERVIEW 168 FIGURE 40 ADM: COMPANY SNAPSHOT 169 TABLE 124 ADM: PRODUCTS OFFERED 170 TABLE 125 ADM: OTHERS, 2021 170 TABLE 126 ADM: PRODUCT LAUNCHES, 2020 171 14.1.2 KONINKLIJKE DSM N.V. 172 TABLE 127 KONINKLIJKE DSM N.V.: BUSINESS OVERVIEW 172 FIGURE 41 KONINKLIJKE DSM N.V.: COMPANY SNAPSHOT 173 TABLE 128 KONINKLIJKE DSM N.V.: PRODUCTS OFFERED 173 TABLE 129 KONINKLIJKE DSM N.V.: DEALS, 2020 174 14.1.3 DUPONT NUTRITION & BIOSCIENCES (DANISCO ANIMAL NUTRITION) 176 TABLE 130 DUPONT NUTRITION & BIOSCIENCES: BUSINESS OVERVIEW 176 FIGURE 42 DUPONT NUTRITION & BIOSCIENCES: COMPANY SNAPSHOT 177 TABLE 131 DUPONT NUTRITION & BIOSCIENCES: PRODUCTS OFFERED 177 TABLE 132 DUPONT NUTRITION & BIOSCIENCES: DEALS, 2019-2021 178 TABLE 133 DUPONT NUTRITION & BIOSCIENCES: PRODUCT LAUNCHES, 2019 178 TABLE 134 DUPONT NUTRITION & BIOSCIENCES: OTHERS, 2020 179 14.1.4 CARGILL INCORPORATED 180 TABLE 135 CARGILL INCORPORATED: BUSINESS OVERVIEW 180 FIGURE 43 CARGILL INC.: COMPANY SNAPSHOT 180 TABLE 136 CARGILL INCORPORATED: PRODUCTS OFFERED 181 TABLE 137 CARGILL INCORPORATED: DEALS, 2020 181 TABLE 138 CARGILL INCORPORATED: OTHERS, 2022 181 14.1.5 NOVOZYMES 183 TABLE 139 NOVOZYMES: BUSINESS OVERVIEW 183 FIGURE 44 NOVOZYMES: COMPANY SNAPSHOT 184 TABLE 140 NOVOZYMES: PRODUCTS OFFERED 184 TABLE 141 NOVOZYMES: DEALS, 2020 185 14.1.6 KEMIN INDUSTRIES INC. 186 TABLE 142 KEMIN INDUSTRIES INC.: BUSINESS OVERVIEW 186 TABLE 143 KEMIN INDUSTRIES INC.: PRODUCTS OFFERED 187 TABLE 144 KEMIN INDUSTRIES: PRODUCT LAUNCHES, 2020 187 14.1.7 NUTRECO 188 TABLE 145 NUTRECO: BUSINESS OVERVIEW 188 FIGURE 45 NUTRECO: COMPANY SNAPSHOT 188 TABLE 146 NUTRECO: PRODUCTS OFFERED 189 TABLE 147 NUTRECO: DEALS 2019-2020 189 14.1.8 CHR. HANSEN HOLDING A/S 191 TABLE 148 CHR. HANSEN HOLDING A/S: BUSINESS OVERVIEW 191 FIGURE 46 CHR. HANSEN HOLDING A/S: COMPANY SNAPSHOT 192 TABLE 149 CHR. HANSEN HOLDING A/S: PRODUCTS OFFERED 192 TABLE 150 CHR. HANSEN HOLDING A/S: PRODUCT LAUNCHES, 2019-2021 193 TABLE 151 CHR. HANSEN HOLDING A/S: DEALS, 2020 193 14.1.9 BLUESTAR ADISSEO CO. LTD. 195 TABLE 152 BLUESTAR ADISSEO: BUSINESS OVERVIEW 195 FIGURE 47 BLUESTAR ADISSEO CO. LTD.: COMPANY SNAPSHOT 196 TABLE 153 BLUESTAR ADISSEO CO. LTD.: PRODUCTS OFFERED 196 TABLE 154 BLUESTAR ADISSEO CO. LTD.: DEALS, 2020 197 14.1.10 ALLTECH 199 TABLE 155 ALLTECH: BUSINESS OVERVIEW 199 TABLE 156 ALLTECH: PRODUCTS OFFERED 199 14.1.11 EVONIK INDUSTRIES 201 TABLE 157 EVONIK INDUSTRIES: BUSINESS OVERVIEW 201 FIGURE 48 EVONIK INDUSTRIES: COMPANY SNAPSHOT 202 TABLE 158 EVONIK INDUSTRIES: PRODUCTS OFFERED 202 TABLE 159 EVONIK INDUSTRIES: PRODUCT LAUNCHES, 2020 203 14.1.12 LALLEMAND INC. 204 TABLE 160 LALLEMAND INC.: BUSINESS OVERVIEW 204 TABLE 161 LALLEMAND INC.: PRODUCTS OFFERED 204 TABLE 162 LALLEMAND INC.: OTHER DEVELOPMENTS, 2019-2020 205 14.1.13 BIORIGIN 206 TABLE 163 BIORIGIN: BUSINESS OVERVIEW 206 TABLE 164 BIORIGIN: PRODUCTS OFFERED 206 TABLE 165 BIORIGIN: DEALS, 2019 207 14.1.14 LAND O’LAKES 208 TABLE 166 LAND O’LAKES: BUSINESS OVERVIEW 208 FIGURE 49 LAND O’LAKES: COMPANY SNAPSHOT 208 TABLE 167 LAND O’LAKES: PRODUCTS OFFERED 209 TABLE 168 LAND O’LAKES: OTHERS, 2019 209 TABLE 169 LAND O’LAKES: DEALS, 2019 210 14.1.15 LESAFFRE 211 TABLE 170 LESAFFRE: BUSINESS OVERVIEW 211 TABLE 171 LESAFFRE: PRODUCTS OFFERED 211 TABLE 172 LESAFFRE: OTHER DEVELOPMENTS, 2019-2020 212 TABLE 173 LESAFFRE: PRODUCT LAUNCHES, 2019 212 14.1.16 CALPIS CO LTD 214 TABLE 174 CALPIS CO LTD.: BUSINESS OVERVIEW 214 14.1.17 AB VISTA 215 14.1.18 PURE CULTURES 215 14.1.19 DR. ECKEL ANIMAL NUTRITION GMBH & CO. KG 216 14.1.20 UNIQUE BIOTECH 217 *Details on Business overview, Products offered, Recent Developments, MNM view might not be captured in case of unlisted companies. 15 ADJACENT AND RELATED MARKETS 218 15.1 INTRODUCTION 218 TABLE 175 ADJACENT MARKETS TO ANIMAL INTESTINAL HEALTH 218 15.2 LIMITATIONS 218 15.3 PHYTOGENIC FEED ADDITIVES MARKET 219 15.3.1 MARKET DEFINITION 219 15.3.2 MARKET OVERVIEW 219 TABLE 176 PHYTOGENIC FEED ADDITIVES MARKET, BY SOURCE, 2016–2019 (USD MILLION) 219 TABLE 177 PHYTOGENIC FEED ADDITIVES MARKET, BY SOURCE, 2020–2025 (USD MILLION) 220 15.4 PROBIOTICS IN ANIMAL FEED MARKET 220 15.4.1 MARKET DEFINITION 220 TABLE 178 PROBIOTICS IN ANIMAL FEED MARKET, BY LIVESTOCK, 2017–2020 (USD MILLION) 220 TABLE 179 PROBIOTICS IN ANIMAL FEED MARKET, BY LIVESTOCK, 2021–2026 (USD MILLION) 221 16 APPENDIX 222 16.1 DISCUSSION GUIDE 222 16.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 226 16.3 AVAILABLE CUSTOMIZATION 228 16.4 RELATED REPORTS 229 16.5 AUTHOR DETAILS 230
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(非耐久財)の最新刊レポートMarketsandMarkets 社の最新刊レポート
本レポートと同じKEY WORD(aquaculture)の最新刊レポート
よくあるご質問MarketsandMarkets社はどのような調査会社ですか?マーケッツアンドマーケッツ(MarketsandMarkets)は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/07 10:27 155.63 円 167.26 円 203.27 円 |